rs116938497

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_012338.4(TSPAN12):​c.360+9A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0097 in 1,610,184 control chromosomes in the GnomAD database, including 109 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0076 ( 6 hom., cov: 32)
Exomes 𝑓: 0.0099 ( 103 hom. )

Consequence

TSPAN12
NM_012338.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.342

Publications

1 publications found
Variant links:
Genes affected
TSPAN12 (HGNC:21641): (tetraspanin 12) The protein encoded by this gene is a member of the transmembrane 4 superfamily, also known as the tetraspanin family. Most of these members are cell-surface proteins that are characterized by the presence of four hydrophobic domains. The proteins mediate signal transduction events that play a role in the regulation of cell development, activation, growth and motility. [provided by RefSeq, Jul 2008]
TSPAN12 Gene-Disease associations (from GenCC):
  • exudative vitreoretinopathy 5
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • TSPAN12-related vitreoretinopathy
    Inheritance: SD Classification: DEFINITIVE Submitted by: ClinGen
  • exudative vitreoretinopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.56).
BP6
Variant 7-120815720-T-C is Benign according to our data. Variant chr7-120815720-T-C is described in ClinVar as Benign. ClinVar VariationId is 358763.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00761 (1160/152344) while in subpopulation NFE AF = 0.0114 (776/68034). AF 95% confidence interval is 0.0107. There are 6 homozygotes in GnomAd4. There are 526 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 1160 AD,SD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TSPAN12NM_012338.4 linkc.360+9A>G intron_variant Intron 5 of 7 ENST00000222747.8 NP_036470.1 O95859-1A0A024R740
TSPAN12XM_005250239.4 linkc.360+9A>G intron_variant Intron 6 of 8 XP_005250296.1 O95859-1A0A024R740
TSPAN12XM_047420095.1 linkc.360+9A>G intron_variant Intron 6 of 8 XP_047276051.1
TSPAN12XM_047420096.1 linkc.286-5150A>G intron_variant Intron 5 of 7 XP_047276052.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TSPAN12ENST00000222747.8 linkc.360+9A>G intron_variant Intron 5 of 7 1 NM_012338.4 ENSP00000222747.3 O95859-1

Frequencies

GnomAD3 genomes
AF:
0.00762
AC:
1160
AN:
152226
Hom.:
6
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00217
Gnomad AMI
AF:
0.0154
Gnomad AMR
AF:
0.0109
Gnomad ASJ
AF:
0.0185
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00186
Gnomad FIN
AF:
0.000753
Gnomad MID
AF:
0.0190
Gnomad NFE
AF:
0.0114
Gnomad OTH
AF:
0.0124
GnomAD2 exomes
AF:
0.00777
AC:
1927
AN:
248058
AF XY:
0.00795
show subpopulations
Gnomad AFR exome
AF:
0.00182
Gnomad AMR exome
AF:
0.00850
Gnomad ASJ exome
AF:
0.0139
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000852
Gnomad NFE exome
AF:
0.0119
Gnomad OTH exome
AF:
0.00926
GnomAD4 exome
AF:
0.00992
AC:
14458
AN:
1457840
Hom.:
103
Cov.:
30
AF XY:
0.00980
AC XY:
7109
AN XY:
725246
show subpopulations
African (AFR)
AF:
0.00162
AC:
54
AN:
33370
American (AMR)
AF:
0.00864
AC:
384
AN:
44462
Ashkenazi Jewish (ASJ)
AF:
0.0156
AC:
406
AN:
26044
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39606
South Asian (SAS)
AF:
0.00200
AC:
172
AN:
85950
European-Finnish (FIN)
AF:
0.00145
AC:
77
AN:
52938
Middle Eastern (MID)
AF:
0.0151
AC:
87
AN:
5754
European-Non Finnish (NFE)
AF:
0.0114
AC:
12675
AN:
1109470
Other (OTH)
AF:
0.0100
AC:
603
AN:
60246
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
639
1279
1918
2558
3197
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
474
948
1422
1896
2370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00761
AC:
1160
AN:
152344
Hom.:
6
Cov.:
32
AF XY:
0.00706
AC XY:
526
AN XY:
74496
show subpopulations
African (AFR)
AF:
0.00216
AC:
90
AN:
41586
American (AMR)
AF:
0.0109
AC:
167
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.0185
AC:
64
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.00186
AC:
9
AN:
4832
European-Finnish (FIN)
AF:
0.000753
AC:
8
AN:
10626
Middle Eastern (MID)
AF:
0.0204
AC:
6
AN:
294
European-Non Finnish (NFE)
AF:
0.0114
AC:
776
AN:
68034
Other (OTH)
AF:
0.0123
AC:
26
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
61
122
182
243
304
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0100
Hom.:
2
Bravo
AF:
0.00848
Asia WGS
AF:
0.000866
AC:
3
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Exudative vitreoretinopathy 5 Benign:1
Mar 06, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.56
CADD
Benign
14
DANN
Benign
0.84
PhyloP100
0.34
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs116938497; hg19: chr7-120455774; API